- Home
- ยป
- Products & Services
- »
- Immunosuppressant Drugs
Immunosuppressant Drugs
Siroboon Sirolimus 5mg Tablets - Rapamune
Product Brochure
| Strength | 5 mg |
| Composition | Sirolimus |
| Brand | Sirolimus |
| Packaging Size | 3 x 10 Tablets |
| Packaging Type | Strip |
| Form | Tablet |
| Dose Form | Tablet |
| Brand. | Siroboon |
| Manufacturer. | Kachhela Medex Pvt Ltd |
| Treatment | Used for prevention of kidney transplant rejection |
Sirolimus 5 mg Tablets (Siroboon) are used in the management of conditions requiring immunosuppression, particularly in organ transplantation to prevent rejection. Sirolimus works by inhibiting the mammalian target of rapamycin (mTOR), a key regulator of cell growth and immune response, thereby reducing the activity of T-lymphocytes and preventing immune-mediated damage to transplanted organs.
This oral formulation is typically taken once daily, providing consistent immunosuppressive effect and supporting long-term graft survival. It is often used as part of combination therapy in transplant protocols and may also be utilized in certain other conditions involving abnormal cell proliferation.
Manufactured under stringent pharmaceutical quality standards, the tablets ensure consistent efficacy, stability, and patient compliance. Sirolimus is widely recognized for its role in transplant medicine and is also marketed under well-known brand names such as Rapamune.
1mg Rapacan Sirolimus Tablet
| Strength | 1 mg |
| Brand | Rapacan |
| Packaging Size | 1 x 10 Tablet |
| Packaging Type | Alu Alu |
| Form | Tablet |
| Manufcatured By | Eris |
| Treatment | Prevents Organ Rejection In Transplant Patients |
Rapacan Sirolimus Tablet contains Sirolimus, an immunosuppressant medication used primarily to prevent organ rejection in patients who have undergone kidney transplants. Sirolimus works by suppressing the body's immune response, helping to prevent the immune system from attacking the transplanted organ. This medication is often used in combination with other immunosuppressants, such as corticosteroids and cyclosporine.
Indications for Rapacan Sirolimus Tablet include:
- Organ Transplantation: Primarily indicated for preventing organ rejection in kidney transplant recipients.
Dosage and Administration:
- The dosage of Rapacan is individualized based on the patient's medical condition, body weight, and response to therapy. It is usually taken once daily, and regular blood tests may be required to monitor drug levels and kidney function.
Common side effects of Rapacan Sirolimus Tablet may include:
- Increased risk of infection
- Elevated blood cholesterol and triglyceride levels
- Delayed wound healing
- Mouth sores
- Gastrointestinal disturbances such as diarrhea or nausea
Packaging:
Rapacan Sirolimus Tablets are typically packaged in blister packs, with each pack containing 10 tablets. This packaging ensures the stability and integrity of the medication.
Rapacan Sirolimus Tablet is a critical medication for kidney transplant patients, helping to ensure the long-term success of the transplant by preventing organ rejection.
1mg Siroash Sirolimus Tablets
| Strength | 1 mg |
| Brand | Siroash |
| Packaging Size | 30 tablets |
| Packaging Type | Box |
| Form | Tablet |
| Shelf Life | 24 months |
| Country Of Origin | India |
| Manufacturer. | Asher Pharmaceuticals |
180mg Mycept S Mycophenolic Acid Tablet
Product Brochure
| Strength | 180 mg |
| Release Form | Delayed Release |
| Brand | Mycept S |
| Packaging Size | 10 tablets |
| Packaging Type | Strip |
| Manufacturer. | Panacea Biotec |
| Treatment | Used In The Treatment Of Prevention Of Organ Rejection In Transplant Patients |
Brand Name: Mycept S
Generic Name: Mycophenolic Acid (Enteric-Coated)
Strength: 180 mg
Dosage Form: Tablet (Enteric-Coated)
Therapeutic Category: Immunosuppressant
Manufacturer/Marketer: Zydus Lifesciences Ltd.
Mycept S 180mg Tablet contains mycophenolic acid, an immunosuppressive agent used to prevent organ rejection in patients undergoing kidney, liver, or heart transplantation. It is commonly used in combination with other immunosuppressants such as cyclosporine and corticosteroids.
The enteric-coated formulation helps reduce gastrointestinal side effects and ensures targeted release in the intestine. Mycophenolic acid works by inhibiting lymphocyte proliferation, thereby suppressing immune responses that can lead to graft rejection.
Indications / Uses- Prevention of organ rejection (kidney, liver, heart transplants)
- Autoimmune disorders (in selected cases as prescribed)
Mycophenolic acid inhibits inosine monophosphate dehydrogenase (IMPDH), an enzyme essential for purine synthesis in lymphocytes. This results in reduced proliferation of T and B lymphocytes, suppressing immune responses.
Dosage & Administration- Taken orally as prescribed by a physician
- Usually given in combination with other immunosuppressive agents
- Tablets should be swallowed whole (do not crush or chew)
1mg Prograf Tacrolimus Hard Capsule
| Brand | Prograf |
| Manufacturer | Astellas |
| Strength | 1 mg |
| Packaging Type | Box |
| Packaging Size | 50 capsules |
| Prescription Type | Prescription |
| Form | Capsule |
The amount of Prograf 1mg Hard Capsule you take and how often you take it depends on the type of transplant you have, your body weight, and what other medicines you are taking. Follow your doctor’s instructions carefully. You should take it on an empty stomach, at least 1 hour before or 2 hours after a meal. Take this medicine regularly to get the maximum benefit and keep taking it, even if you feel well. If you stop taking it, you may increase the chances of rejecting your transplanted organ.
Prograf 1mg Hard Capsule has many potential side effects. It can cause or worsen diabetes and kidney problems. These need urgent medical attention. Other common side effects include tremor, infections, high blood pressure, headache, and insomnia. If the side effects do not go away or get worse, tell your doctor. Prograf 1mg Hard Capsule lowers your immune system making you susceptible to catching more infections than usual.
Before taking this medicine, tell your doctor if you have kidney, liver, or heart problems, diabetes, or high blood pressure. Also let your doctor know what other medications you are taking, especially for infections, pain, and arthritis. These and others may affect, or be affected by, this medicine. You should limit your exposure to the sun and UV (ultraviolet) light while taking it because immunosuppressants could increase your risk of skin cancer.
Both men and women using this medicine should use effective birth control to prevent pregnancy. This medicine is not normally recommended during pregnancy or while breastfeeding unless it is clearly needed. Before and during treatment you will need frequent medical tests to monitor your progress, and your blood pressure will need to be checked often.
Thymoglobulin 25 Mg Injection
| Brand | Thymoglobulin |
| Strength | 5 mg / ml |
| Pack size | 5 ml vial |
| Product Form | Injection |
| Usage type | Hospital |
| Manufacturer | Sanofi Genzyme |
| Administration | IV |
Brand Name: THYMOGLOBULIN 25
Composition: Anti-Thymocyte Globulin (Rabbit) 25 mg
Dosage Form: Lyophilized Powder for Injection
Therapeutic Class: Immunosuppressant
Indication: Prevention and treatment of organ transplant rejection, aplastic anemia
Administration Route: Intravenous Infusion
Age Group: Adults & Children
THYMOGLOBULIN 25 is a highly specialized immunosuppressive biologic designed to modulate the body’s immune response in critical clinical conditions. It contains purified anti-thymocyte antibodies that selectively target and reduce circulating T-lymphocytes, which play a central role in graft rejection and immune-mediated disorders.
This formulation is widely used in transplant medicine to enhance graft acceptance and improve long-term transplant outcomes. Its controlled immunosuppressive action also makes it valuable in the management of severe hematological conditions such as aplastic anemia. Designed for precision therapy, it allows clinicians to achieve effective immune modulation while maintaining treatment control in complex cases.
โญ Key Benefits- Reduces risk of organ transplant rejection
- Provides targeted T-cell suppression
- Supports graft survival and stability
- Useful in severe immune-mediated conditions
- Reliable in critical care and transplant protocols
Anti-thymocyte globulin binds to T-lymphocytes, leading to their depletion and suppression of immune activity, thereby reducing immune-mediated damage.
๐ UsageTHYMOGLOBULIN 25 is used in immune suppression therapy for transplant and hematological conditions.
It is typically used for:
- Prevention of organ transplant rejection
- Treatment of acute rejection episodes
- Management of aplastic anemia
Administered as:
- Slow intravenous infusion
- In controlled hospital settings
- Under specialist supervision with monitoring